会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Implantable cardioverter
    • 可植入心脏转复器
    • US4403614A
    • 1983-09-13
    • US239007
    • 1981-02-27
    • William R. EngleE. Neil Moore, Jr.Joseph F. Spear, Jr.Ronald H. Rockland
    • William R. EngleE. Neil Moore, Jr.Joseph F. Spear, Jr.Ronald H. Rockland
    • A61N1/38A61N1/39A61N1/36
    • A61N1/385A61N1/3956
    • A body implantable ventricular cardioverting system. Circuitry is provided which detects the onset of a malignant ventricular tachyarrhythmia and provides a cardioverting signal in response thereto. The cardioverting signal has an energy level that is high relative to the pacing threshhold but below that necessary for defibrillation. In this manner, a ventricular tachyarrhythmia can be cardioverted before the onset of fibrillation and at a lower energy than required for defibrillation. Dependent on such factors as patient threshholds, the tissue/electrode interface and the electrode system employed, the energy level of the cardioverting signal is from 5 millijoules to 15 joules. The system can be configured such that increasingly malignant tachyarrhythmias result in higher energy cardioverting signals, including signals capable of defibrillation. Successful cardioversion with a signal having an energy level lower than necessary for defibrillation reduces the physical damage to the heart as well as the trauma to and discomfort of the patient.
    • 身体植入式心室心律转复系统。 提供电路,其检测恶性室性快速性心律失常的发作,并提供响应于其的心律转换信号。 心跳转换信号的能量水平相对于起搏阈值高,但低于除颤所需的水平。 以这种方式,可以在纤维颤动发作之前以比除颤所需的能量更低的能量心律失常。 根据患者阈值,组织/电极界面和电极系统等因素,心脏转换信号的能量水平从5毫焦耳到15焦耳。 可以配置该系统,使得越来越恶性的快速性心律失常导致更高的能量心律转换信号,包括能够除颤的信号。 具有低于除颤所需能量水平的信号的成功的心脏复律减少了对心脏的物理损伤以及患者的创伤和不适。
    • 2. 发明授权
    • Implantable cardioverter
    • 可植入心脏转复器
    • US4375817A
    • 1983-03-08
    • US219254
    • 1980-12-22
    • William R. EngleE. Neil Moore, Jr.Joseph F. Spear, Jr.Ronald H. Rockland
    • William R. EngleE. Neil Moore, Jr.Joseph F. Spear, Jr.Ronald H. Rockland
    • A61N1/38A61N1/39A61N1/36
    • A61N1/385A61N1/3962
    • A body implantable ventricular cardioverter. Circuitry is provided which detects the onset of a malignant ventricular tachyarrhythmia and provides a cardioverting signal in response thereto. The cardioverting signal has an energy level that is high relative to the pacing threshold but below that necessary for defibrillation. In this manner, a ventricular tachyarrhythmia can be cardioverted before the onset of fibrillation and at a lower energy than required for defibrillation. Dependent on such factors as patient thresholds, the tissue/electrode interface and the electrode system employed, the energy level of the cardioverting signal is from 5 millijoules to 15 joules. The system can be configured such that increasingly malignant tachyarrhythmias result in higher energy cardioverting signals, including signals capable of defibrillation. Successful cardioversion with a signal having an energy level lower than necessary for defibrillation reduces the physical damage to the heart as well as the trauma to and discomfort of the patient.
    • 身体植入式心室心律转换器。 提供电路,其检测恶性室性快速性心律失常的发作,并提供响应于其的心律转换信号。 心脏转换信号具有相对于起搏阈值高但低于除颤所必需的能级。 以这种方式,可以在纤维颤动发作之前以比除颤所需的能量更低的能量心律失常。 取决于诸如患者阈值,使用的组织/电极界面和电极系统等因素,心律转换信号的能量水平为5毫焦耳至15焦耳。 可以配置该系统,使得越来越恶性的快速性心律失常导致更高的能量心律转换信号,包括能够除颤的信号。 具有低于除颤所需能量水平的信号的成功的心脏复律减少了对心脏的物理损伤以及患者的创伤和不适。